Vitreal Penetration of Oral and Topical Moxifloxacin in Humans

American Journal of Ophthalmology

Volumn 143, Issue 2, 2007, Pages 338-340

  Fuller, Jeffrey J ^a   Lott, McGregor N ^b   Henson, Nathanael M ^b   Bhatti, Asmaa A ^b   Singh, Harinderjit ^c   McGwin Jr , Gerald ^d   Marcus, Dennis M ^c  

^a UNIVERSITY OF IOWA   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c Southeast Retina Center   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MOXIFLOXACIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG PENETRATION; DRUG TISSUE LEVEL; ENDOPHTHALMITIS; FEMALE; HUMAN; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE INFECTION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; TOPICAL TREATMENT; VITREOUS BODY;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUINOLINES; VITRECTOMY; VITREOUS BODY;

EID: 33846361026     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2006.09.023     Document Type: Article

References (5)

1. Vedantham V, Lalitha P, Velpandian T, Ghose S, Mahalakshmi R, Ramasamy K. Vitreous and aqueous penetration of orally administered moxifloxacin in humans. Eye. Forthcoming.
2. Hariprasad S.M., Shah G.K., Mieler W.F., et al. Vitreous and aqueous penetration of orally administered moxifloxacin in humans. Arch Ophthalmol 124 (2006) 178-182
3. Hariprasad S.M., Blinder K.J., Shah G.K., et al. Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous. Arch Ophthalmol 123 (2005) 39-44
4. Costello P., Bakri S.J., Beer P.M., et al. Vitreous penetration of topical moxifloxacin and gatifloxacin in humans. Retina 26 (2006) 191-195
5. Bauernfeind A. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin, and ciprofloxacin. J Antimicrob Chemother 40 (1997) 639-651